Literature DB >> 15109123

Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation.

Murat Beyzadeoglu1, Kaan Oysul, Bahar Dirican, Fikret Arpaci, Arzu Balkan, Serdar Surenkok, Yucel Pak.   

Abstract

The aim of this study is to evaluate the incidence of interstitial pneumonitis following fractionated total body irradiation conditioning for bone marrow transplantation with varying lung doses due to shielding technique and different dose-rates. Between 1987 and 2001, a total number of 105 patients have received total body irradiation conditioning for bone marrow transplantation for hematological malignancies at Gulhane Military Medical School. Twelve Gy fractionated total body irradiation was delivered in 6 fractions over 3 consecutive days with Co-60 teletherapy machine. Conditioning therapy included only cyclophosphamide (60 mg/ kg/day for two days) and total body irradiation. The median follow-up for patients was 12 months. Interstitial pneumonitis developed in 10 patients out of 105 patients (9.52%). The median total dose to lung was 9.60 Gy (8.88-10.90). The difference between total lung dose and interstitial pneumonitis was not significant. Pneumonitis development in the high dose-rate (>0.04 Gy/min) group versus low dose-rate (< or =0.04 Gy/min) group was statistically significant. Low dose-rate fractionated total body irradiation is a reliable conditioning program in bone marrow transplantation with effective lung sparing to avoid interstitial pneumonitis.

Entities:  

Mesh:

Year:  2004        PMID: 15109123     DOI: 10.1620/tjem.202.255

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  11 in total

1.  Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group.

Authors:  Natia Esiashvili; Xiaomin Lu; Ken Ulin; Fran Laurie; Sandy Kessel; John A Kalapurakal; Thomas E Merchant; David S Followill; Vythialinga Sathiaseelan; Mary K Schmitter; Meenakshi Devidas; Yichen Chen; Donna A Wall; Patrick A Brown; Stephen P Hunger; Stephan A Grupp; Michael A Pulsipher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-23       Impact factor: 7.038

2.  T lymphocytes and normal tissue responses to radiation.

Authors:  Dörthe Schaue; William H McBride
Journal:  Front Oncol       Date:  2012-09-19       Impact factor: 6.244

Review 3.  Hydrogen as a new class of radioprotective agent.

Authors:  Liren Qian; Jianliang Shen; Yunhai Chuai; Jianming Cai
Journal:  Int J Biol Sci       Date:  2013-09-14       Impact factor: 6.580

4.  Volumetric modulated arc therapy for total body irradiation: A feasibility study using Pinnacle3 treatment planning system and Elekta Agility™ linac.

Authors:  Kirsty Symons; Colm Morrison; Jason Parry; Simon Woodings; Yvonne Zissiadis
Journal:  J Appl Clin Med Phys       Date:  2018-01-24       Impact factor: 2.102

Review 5.  A Century of Radiation Therapy and Adaptive Immunity.

Authors:  Dörthe Schaue
Journal:  Front Immunol       Date:  2017-04-11       Impact factor: 7.561

6.  Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.

Authors:  David S Wenger; Matthew Triplette; Kristina Crothers; Guang-Shing Cheng; Joshua A Hill; Filippo Milano; Shahida Shahrir; Gary Schoch; Lisa K Vande Vusse
Journal:  Biol Blood Marrow Transplant       Date:  2019-10-09       Impact factor: 5.742

7.  Technical note: factors affecting dose distribution in the overlap region of two-segment total body irradiation by helical tomotherapy.

Authors:  HaiYang Wang; JunQi Liu; YiFei Pi; Qi Liu; Yang Mi; XiangXiang Yang; YueXin Guo; RuiTai Fan
Journal:  Radiat Oncol       Date:  2020-11-07       Impact factor: 3.481

8.  Once-a-day fractionated total-body irradiation: A regimen tailored to local logistics in allogeneic stem cell transplantation for acute lymphoblastic leukemia.

Authors:  Nour Ben Abdeljelil; Saloua Ladeb; Talel Dahmani; Lotfi Kochbati; Amel Lakhal; Rym El Fatmi; Lamia Torjemane; Dorra Belloumi; Mounir Besbes; Farouk El Benna; Chiraz Nasr Ben Ammar; Tarek Ben Othman
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-28

9.  Dosimetric Evaluation Between the Conventional Volumetrically Modulated Arc Therapy (VMAT) Total Body Irradiation (TBI) and the Novel Simultaneous Integrated Total Marrow Approach (SIMBa) VMAT TBI.

Authors:  Dennis Stanley; Kristen McConnell; Zohaib Iqbal; Ashlyn Everett; Jonathan Dodson; Kimberly Keene; Andrew McDonald
Journal:  Cureus       Date:  2021-06-14

10.  Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation.

Authors:  Dong-Yun Kim; Il Han Kim; Sung-Soo Yoon; Hyoung Jin Kang; Hee Young Shin; Hyun-Cheol Kang
Journal:  Radiat Oncol       Date:  2018-09-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.